peppa dong
2023-07-21
s,obxu%
Nvidia Backed Shares Recursion Pharmaceuticals Continue to Fly 3% Higher Premarket
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":200388314251480,"tweetId":"200388314251480","gmtCreate":1689947681281,"gmtModify":1689947682828,"author":{"id":3526573431177002,"idStr":"3526573431177002","authorId":3526573431177002,"authorIdStr":"3526573431177002","name":"peppa dong","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>s,obxu%</p></body></html>","htmlText":"<html><head></head><body><p>s,obxu%</p></body></html>","text":"s,obxu%","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/200388314251480","repostId":1149490262,"repostType":2,"repost":{"id":"1149490262","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1689941160,"share":"https://www.laohu8.com/m/news/1149490262?lang=&edition=full","pubTime":"2023-07-21 20:06","market":"us","language":"en","title":"Nvidia Backed Shares Recursion Pharmaceuticals Continue to Fly 3% Higher Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=1149490262","media":"Tiger Newspress","summary":"$Recursion Pharmaceuticals(RXRX)$ shares continue to jump 3% higher in premarket trading on Friday. The move was sparked after a $50 million investment from $Nvidia (NVDA)$, which was revealed on July","content":"<html><head></head><body><p><a href=\"https://laohu8.com/S/RXRX\">Recursion Pharmaceuticals</a> shares continue to jump 3% higher in premarket trading on Friday. </p><p>The move was sparked after a $50 million investment from <a href=\"https://laohu8.com/S/NVDA\">Nvidia </a>, which was revealed on July 12. Shares of RXRX rallied more than 75% on July 12. At one point, the stock traded as high as $14.99, up 121% on the day. </p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ccde5bee03d5675d7deee56f7a892bea\" tg-width=\"792\" tg-height=\"620\"/></p><p style=\"text-align: start;\"></p><p style=\"text-align: start;\">All of this stems from a $50 million investment made by Nvidia, “which was implemented as a private investment in public equity.”</p><blockquote>“Recursion will utilize NVDA’s cloud platform to train its AI models using its over 23 petabytes of biological and chemical dataset…</blockquote><blockquote>RXRX said it could potentially use its BioNeMo platform to commercially license or release its AI models.”</blockquote><p style=\"text-align: start;\">The move on July 12 triggered more than 80 million shares of RXRX stock to trade that day. In fact, four of the last six sessions have resulted in a volume that would have exceeded the previous one-day record.</p><p style=\"text-align: start;\">Luckily for the bears, this stock doesn’t have a <em>huge</em> short interest — although it is notable — which would have likely triggered a massive upside move. However, bulls are wondering if there’s enough fuel left in the tank to continue to squeeze this one higher.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nvidia Backed Shares Recursion Pharmaceuticals Continue to Fly 3% Higher Premarket</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNvidia Backed Shares Recursion Pharmaceuticals Continue to Fly 3% Higher Premarket\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2023-07-21 20:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p><a href=\"https://laohu8.com/S/RXRX\">Recursion Pharmaceuticals</a> shares continue to jump 3% higher in premarket trading on Friday. </p><p>The move was sparked after a $50 million investment from <a href=\"https://laohu8.com/S/NVDA\">Nvidia </a>, which was revealed on July 12. Shares of RXRX rallied more than 75% on July 12. At one point, the stock traded as high as $14.99, up 121% on the day. </p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ccde5bee03d5675d7deee56f7a892bea\" tg-width=\"792\" tg-height=\"620\"/></p><p style=\"text-align: start;\"></p><p style=\"text-align: start;\">All of this stems from a $50 million investment made by Nvidia, “which was implemented as a private investment in public equity.”</p><blockquote>“Recursion will utilize NVDA’s cloud platform to train its AI models using its over 23 petabytes of biological and chemical dataset…</blockquote><blockquote>RXRX said it could potentially use its BioNeMo platform to commercially license or release its AI models.”</blockquote><p style=\"text-align: start;\">The move on July 12 triggered more than 80 million shares of RXRX stock to trade that day. In fact, four of the last six sessions have resulted in a volume that would have exceeded the previous one-day record.</p><p style=\"text-align: start;\">Luckily for the bears, this stock doesn’t have a <em>huge</em> short interest — although it is notable — which would have likely triggered a massive upside move. However, bulls are wondering if there’s enough fuel left in the tank to continue to squeeze this one higher.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RXRX":"Recursion Pharmaceuticals, Inc.","NVDA":"英伟达"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149490262","content_text":"Recursion Pharmaceuticals shares continue to jump 3% higher in premarket trading on Friday. The move was sparked after a $50 million investment from Nvidia , which was revealed on July 12. Shares of RXRX rallied more than 75% on July 12. At one point, the stock traded as high as $14.99, up 121% on the day. All of this stems from a $50 million investment made by Nvidia, “which was implemented as a private investment in public equity.”“Recursion will utilize NVDA’s cloud platform to train its AI models using its over 23 petabytes of biological and chemical dataset…RXRX said it could potentially use its BioNeMo platform to commercially license or release its AI models.”The move on July 12 triggered more than 80 million shares of RXRX stock to trade that day. In fact, four of the last six sessions have resulted in a volume that would have exceeded the previous one-day record.Luckily for the bears, this stock doesn’t have a huge short interest — although it is notable — which would have likely triggered a massive upside move. However, bulls are wondering if there’s enough fuel left in the tank to continue to squeeze this one higher.","news_type":1},"isVote":1,"tweetType":1,"viewCount":236,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/200388314251480"}
精彩评论